医院住院患者筛查中耳念珠菌实时荧光PCR检测方法的验证
该研究在CAP认证的大型学术医疗中心验证了基于DiaSorin耳念珠菌引物组的实验室自建实时荧光PCR检测方法,用于腋下和腹股沟拭子筛查耳念珠菌定植。方法检测限为1–2 CFU/反应,与其他念珠菌、细菌皮肤共生菌及常见病毒无交叉反应;与培养法平行检测时灵敏度和特异性均为100%。分析前因素如拭子储存时间、温度和转运培养基对检测无显著影响。
要点
- 该实时荧光PCR方法检测耳念珠菌的检测限为1–2 CFU/反应。
- 与培养法平行检测时,PCR方法灵敏度和特异性均为100%。
- 拭子储存时间、温度和转运培养基对耳念珠菌检测无显著影响。
核心结论
- 该实验室自建实时荧光PCR方法可高灵敏、高特异地检测耳念珠菌DNA,适用于医院住院患者筛查。
研究设计与样本
- 在CAP认证的大型学术医疗中心开展的方法学验证研究,采用DiaSorin耳念珠菌引物组在LIAISON MDX热循环仪配合Simplexa Universal Disc上进行实时荧光PCR检测。
主要发现
- 检测限为1–2 CFU/反应,与其他念珠菌、细菌皮肤共生菌及常见病毒无交叉反应。
- 与培养法平行检测时,PCR方法灵敏度和特异性均为100%。
- 该检测方法精密度良好,批内和批间重复变异低。
- 拭子储存时间、温度和转运培养基等分析前因素对检测无显著影响。
临床怎么用
- 该PCR方法可用于医院住院患者耳念珠菌定植筛查,支持感染预防控制工作。
- 该方法可缩短周转时间,并带来显著的健康系统成本节约。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Candida auris is a multidrug-resistant opportunistic fungal pathogen capable of causing serious infections and healthcare-associated outbreaks. Screening for colonization with C. auris has become routine and is recommended in many hospitals and healthcare facilities as an infection control and prevention strategy. Subsequently, and since there are currently no FDA-approved tests for this purpose, clinical microbiology laboratories have become responsible for developing protocols to detect C. auris using axial and inguinal screening swabs. In a College of American Pathologists-accredited large academic healthcare center setting, we implemented a laboratory-developed nucleic-acid amplification test for the detection of C. auris DNA. Our test validation evaluated the performance of the DiaSorin C. auris primer set used in a real-time qualitative PCR assay on the LIAISON MDX thermocycler with the Simplexa Universal Disc. The assay was highly sensitive and specific, with a limit of detection of 1-2 CFU/reaction, with no observed cross-reactivity with other Candida spp., bacterial skin commensal organisms or commonly encountered viruses. When run in parallel with a culture-based detection method, the PCR assay was 100% sensitive and specific. The assay was precise, with low variability between replicates within and between runs. Lastly, pre-analytical factors, including swab storage time, temperature, and transport media, were assessed and found to have no significant effect on the detection of C. auris at variable concentrations. Taken together, this study expands the available options for nucleic acid detection of C. auris and characterizes pre-analytical factors for implementation in both high- and low-volume laboratory settings. IMPORTANCE: This study overviews the validation and implementation of a molecular screening tool for the detection of Candida auris in a College of American Pathologist-accredited clinical laboratory. This molecular laboratory-developed test is both highly sensitive and specific and has significant health-system cost-savings associated with significantly reduced turn-around-time compared to traditional standard-of-care culture-based work up. This method and workflow is of interest to support clinical microbiology diagnostics and to help aid in hospital inpatient, and infection prevention control screening.
引用
- Franco LC, Ahmed M, Kendra CG, et al. Validation of a qualitative real-time PCR assay for the detection of Candida auris in hospital inpatient screening. J Clin Microbiol. 2024. PMID: 38690882. doi:10.1128/jcm.00158-24
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。